A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Acerta Pharma BV
Massachusetts General Hospital
Taproot Health
City of Hope Medical Center
Dartmouth-Hitchcock Medical Center
Karyopharm Therapeutics Inc
Scripps Health
Columbia University
Northwestern University
Barbara Ann Karmanos Cancer Institute
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
Eli Lilly and Company
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Canadian Cancer Trials Group
Mayo Clinic
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Wisconsin, Madison
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Maryland, Baltimore
University of Maryland, Baltimore
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Mayo Clinic
Fred Hutchinson Cancer Center
Takeda
Yale University
Wake Forest University Health Sciences
Calithera Biosciences, Inc
Ohio State University Comprehensive Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
California Cancer Consortium
UNC Lineberger Comprehensive Cancer Center